ReviewCurrent rheumatology reports2004
Henoch-Schönlein purpura.
Review in Current rheumatology reports, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 123 citations in OpenAlex.
- An Unusual Presentation of Henoch-Schönlein Purpura With Penile Involvement in a 10-Year-Old Boy From Mexico.Cureus · 2025Article
- Epigastric pain of unknown origin, esophageal and gastric involvement: a Henoch-Schönlein Purpura case report.Frontiers in medicine · 2025Article
- Article
- Identification of key genes and imbalance of immune cell infiltration in immunoglobulin A associated vasculitis nephritis by integrated bioinformatic analysis.Frontiers in immunology · 2023Article
- Focal Seizures and Posterior Reversible Encephalopathy Syndrome as Presenting Signs of IgA Vasculitis/Henoch-Schoenlein Purpura-An Educative Case and Systematic Review of the Literature.Frontiers in neurology · 2021Article
- Henoch-Schönlein Purpura Presenting in Association With Neuroblastoma: A Case Report.Frontiers in pediatrics · 2020Article
- Analysis of seasonal tendencies in pediatric Henoch-Schönlein purpura and comparison with outbreak of infectious diseases.Medicine · 2018Article
- Unusual presentation of Henöch-Schonlein purpura.BMJ case reports · 2018Article
- Adult-Onset Henoch-Schonlein Purpura Duodenitis.Journal of clinical medicine research · 2017Article
- Association of TLR4 gene polymorphisms with childhood Henoch-Schönlein purpura in a Chinese population.Rheumatology international · 2017Article
- Henoch-Schönlein Purpura with Concurrent Cytomegalovirus Duodenitis.Infection & chemotherapy · 2017Article
- Central Nervous System Involvement in Henoch-Schonlein Purpura in Children and Adolescents.Case reports in pediatrics · 2017Article
- Hematologic and immunological characteristics of Henoch-Schönlein purpura in rat and rabbit models induced with ovalbumin based on type III hypersensitivity.Scientific reports · 2015Article
- Adult Henoch-Schönlein purpura associated with small cell lung cancer: A case report and review of the literature.Oncology letters · 2013Article
- Scrotal involvement in an adult with Henoch-Schönlein purpura.Clinical rheumatology · 2013Review
- Investigation of the change in CD4⁺ T cell subset in children with Henoch-Schonlein purpura.Rheumatology international · 2012Article
- Henoch-Schönlein purpura associated with a neuroblastoma: Report of one case and a review of the literature.Intractable & rare diseases research · 2012Article
- Pediatric vasculitis.Current rheumatology reports · 2012Review
- Article
- Coexistence of vasculitides with familial Mediterranean fever.Rheumatology international · 2011Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Henoch-Schönlein purpura (HSP) is a multisystem immunoglobulin A-mediated vasculitis with a self-limited course affecting the skin, joints, gastrointestinal tract, and kidneys. HSP occurs most often in children between the ages of 3 and 10 years, and presents classically with a unique distribution of the rash to the lower extremities and the buttocks area. For this reason, a skin biopsy in children is rarely necessary for diagnosis. However, in the very young age children and adults, the rash is not classically distributed, and therefore a skin biopsy is often needed. Although there are currently no prospective controlled studies on the treatment of the different manifestations of HSP, there are several retrospectively designed studies and other physicians' personal experiences supporting the use of steroids in patients with severe gastrointestinal, severe renal, central nervous system, and testicular involvements. Severe renal and central nervous system disease may lead to life-threatening conditions, and immunosuppressive agents and plasmapheresis may be needed. The overall prognosis in HSP is excellent, but the long-term morbidity depends on the renal and neurologic involvement. One third to one half of these patients will have one or more recurrences of symptoms, usually within 6 weeks, but may occur as late as 3 to 7 years later.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.